Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients

Thorax

Volumn 59, Issue 4, 2004, Pages 334-336

  Al Aloul, M ^a   Crawley, J ^a   Winstanley, C ^b   Hart, C A ^b   Ledson, M J ^a   Walshaw, M J ^a  

^a LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DETERMINATION; ARTICLE; BACTERIAL STRAIN; BODY MASS; BURKHOLDERIA CEPACIA; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE COURSE; EPIDEMIC; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GENOTYPE; GRAM NEGATIVE INFECTION; HUMAN; LUNG FUNCTION; LUNG INFECTION; MALE; MORBIDITY; NUTRITIONAL STATUS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SCHOOL CHILD; SPIROMETRY;

BODY MASS INDEX; CHRONIC DISEASE; COHORT STUDIES; CYSTIC FIBROSIS; DISEASE OUTBREAKS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MORBIDITY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 1942469578     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2003.014258     Document Type: Article

References (15)

1. Cheng K, Smyth RL, Govan JRW, et al. Spread of β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 1996;348:639-42.
2. Jones AM, Govan JRW, Doherty CJ, et al. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet 2001;358:557-8.
3. Pitt TL. Cross infection of cystic fibrosis patients with Pseudomonas aeruginosa. Trorax 2002;57:921.
4. Scott F, Pitt TL. Identification and characterization of transmissible Pseudomonas aeruginosa strains in UK cystic fibrosis centres. J Cystic Fibrosis 2003;2(Suppl 1):S39.
5. Geddes DM. Of isolates and isolation: Pseudomonas aeruginosa in adults with cystic fibrosis. Lancet 2001;358:522.
6. Jones AM, Dodd ME, Doherty CJ, et al. Increased treatment requirements of patients with cystic fibrosis who harbour a highly transmissible strain of Pseudomonas aeruginosa. Thorax 2002;57:924-5.
7. Cystic Fibrosis Trust Antibiotic Group. Antibiotic treatment for cystic fibrosis. Kent, UK: Cystic Fibrosis Trust, 2002.
8. Al-Aloul M, Govin B, Stockton PA, et al. Antibiotic related renal impairment in adult cystic fibrosis patients. Thorax 2002;57(Suppl III):iii81.
9. McCallum SJ, Corkill J, Gallagher M, et al. Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonized by P aeruginosa. Loncet 2001;358:558-60.
10. Cystic Fibrosis Trust Control of Infection Group. Pseudomonas aeruginosa: infection in people with cystic fibrosis: suggestions for prevention and infection control. Kent, UK: Cystic Fibrosis Trust, 2001.
11. Speller DE. Hospital acquired infections. In: Topley & Wilson's principles of bacteriology. London: Arnold, 1990:142-67.
12. Ojeniyi B, Peterson US, Hoiby N. Comparison of genome fingerprinting with conventional typing methods used on Pseudomonas aeruginosa isolates from cystic fibrosis patients. APMIS 1993;101:168-75.
13. Williams T. Evaluation of antimicrobial sensitivity patterns as markers of Pseudomonas aeruginosa cross infection at a cystic fibrosis clinic. Br J Biomed Sci 1997;54:181-5.
14. Grundmann H, Schneider C, Hartung D, et al. Discriminatory power of three DNA-based typing techniques for Pseudomonas aeruginosa. J Clin Microbiol 1995;33:528-34.
15. Parsons YN, Panagea S, Smart CH, et al. Use of subtractive hybridisation to identify a diagnostic probe for a cystic fibrosis epidemic strain of Pseudomonas aeruginosa. J Clin Microbiol 2002;40:4607-11.